TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS

This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Boyle, Jeff, Manktelow, Emily
Format:	Patent
Sprache:	eng
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Boyle, Jeff Manktelow, Emily
description	This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediated immunoresponsiveness. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020271648A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020271648A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020271648A13</originalsourceid><addsrcrecordid>eNrjZPAK8QlScHT39_MMDtF19fNw9HN2dVHw9FMI8wwJ8ldwDA52jFTwd1NwdvXxUfB1dfF0DAHJ-_qG-rkqBLkGB_j7BXuGufq5BgfzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjAyA0NzQzsXA0NCZOFQAQOi5f</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS</title><source>esp@cenet</source><creator>Boyle, Jeff ; Manktelow, Emily</creator><creatorcontrib>Boyle, Jeff ; Manktelow, Emily</creatorcontrib><description>This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediated immunoresponsiveness. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management.</description><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200827&DB=EPODOC&CC=US&NR=2020271648A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200827&DB=EPODOC&CC=US&NR=2020271648A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Boyle, Jeff</creatorcontrib><creatorcontrib>Manktelow, Emily</creatorcontrib><title>TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS</title><description>This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediated immunoresponsiveness. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPAK8QlScHT39_MMDtF19fNw9HN2dVHw9FMI8wwJ8ldwDA52jFTwd1NwdvXxUfB1dfF0DAHJ-_qG-rkqBLkGB_j7BXuGufq5BgfzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjAyA0NzQzsXA0NCZOFQAQOi5f</recordid><startdate>20200827</startdate><enddate>20200827</enddate><creator>Boyle, Jeff</creator><creator>Manktelow, Emily</creator><scope>EVB</scope></search><sort><creationdate>20200827</creationdate><title>TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS</title><author>Boyle, Jeff ; Manktelow, Emily</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020271648A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>Boyle, Jeff</creatorcontrib><creatorcontrib>Manktelow, Emily</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Boyle, Jeff</au><au>Manktelow, Emily</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS</title><date>2020-08-27</date><risdate>2020</risdate><abstract>This disclosure relates generally to the field of immunological-based diagnostic assays including an assay to measure cell-mediated immunoresponsiveness. The present disclosure teaches determination of the state, progression and/or severity of disease conditions based on a subject's cell-mediated immunoresponsiveness. The assay contemplated herein is capable of integration into standard pathology architecture to provide a diagnostic reporting system and to facilitate point of care clinical management.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2020271648A1
source	esp@cenet
subjects	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
title	TLR AGONIST-ENHANCED IN VITRO ASSAY OF CELL MEDIATED IMMUNE RESPONSIVENESS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A19%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Boyle,%20Jeff&rft.date=2020-08-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020271648A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true